Is Estia Health Ltd a takeover target?

The Estia Health share price has risen 25% so far in 2017

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Estia Health Ltd (ASX: EHE) share price has jumped more than 3% today after the company revealed a potential takeover plot for its business.

Estia Health, an aged care operator, made the announcement shortly after the market had closed on Wednesday. It said that it had become aware that a subsidiary of Sentinel Portfolio Management Pty Ltd, Sentinel Health Trust ("Sentinel"), had indicated its intention to turn its 4.99% stake in Estia into a controlling position with the aid of one of Estia's fellow aged-care operators.

Essentially, Sentinel would turn its stake into a controlling position, meaning it would hold more than 50% of the company's stock (giving it control over the business). It would then sell the operating business of 60 (out of 68) of Estia Health's target sites to that business for $300 million plus the assumption of specific liabilities, although it seems Sentinel would retain ownership of the property for those sites.

It also said it had found a potential buyer for the remaining eight sites. Reportedly valued at $60 million, this sale would involve both the operations and the real property of those sites.

As it stands, Estia Health said it had not been in contact with Sentinel, nor had a proposal of any sort actually been received from the business. It said "the board of EHE advises shareholders to take no action as a result of this information at this time. Further announcements will be made as required."

The jump in Estia Health's share price today has given the stock a total rise of 5% over the past month and a little over 25% year-to-date. By comparison, its rivals, Regis Healthcare Ltd (ASX: REG) and Japara Healthcare Ltd (ASX: JHC), are both trading in the red so far in 2017, with Japara down 6.6%.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »